{
    "symbol": "IMCC",
    "quarter": 3,
    "year": 2022,
    "date": "2022-11-14 15:11:04",
    "content": " Revenues for Q3, 2022 were $14.2 million, compared to $8 million on Q3, 2021, an increase of 78% representing a 12% sequential organic growth. The increase in revenues is finally attributed to the increase in the quantity of medical cannabis products sold, as well as from the higher average selling price per gram the company realized from its portfolio of premium and ultra premium branded cannabis products in Israel. The company sold 1453 kilograms of dried flowers in Q3, 2022, at an average selling price of $9.08 per gram compared to 1175 kilograms for the same period in 2021 at an average selling price of $6.61 per gram. Sales and marketing expenses in Q3, 2022 were $2.8 million compared to $1.7 million in Q3, 2021. Total operating expenses in Q3, 2022 were $7.5 million, compared to $8 million in Q3, 2021. Non-IFRS adjusted EBITDA loss from continuing operations in Q3, 2022 was $3.7 million compared to an adjusted EBITDA loss of $2.3 million in Q3, 2021 the increase is mainly attributable to corporate expenses and related legal expenses in connection with the company's exits from the Canadian markets. Net loss from continuing operations for Q3, 2022 was $4.5 million compared with net income of $0.8 million in Q3, 2021. Basic loss per share attributable to equity holders of the company from continuing operations was $0.6 compared to basic earnings per share of $0.03 in Q3, 2021. Diluted loss per share attributable to equity holders of the company from continuing operations was $0.6 compared to diluted loss per share of $0.09 in Q3, 2021. Net loss from discontinued operations for Q3, 2022 was $123.6 million compared with a loss of $6.5 million in Q3, 2021. Basic and diluted loss per share attributable to equity holders of the company from discontinued operations was $1.75 compared to basically diluted loss per share of $0.1 in Q3, 2021. As of September 30 2022, the company's cash position from continuing operations was $3.2 million and its working capital from continued operation was $10.3 million."
}